The largest holder of Encompass Health stock is BlackRock Advisors LLC, with 9.8 million shares (9.96% of the company), worth about $1.18 billion as of September 25, 2026. The 10 largest holders together own 41.1%.
In Q2 2026, 619 institutional holdings reports listed shares worth $9.74 billion.
Insiders reported 91 transactions in the last two years: 10 sales worth $42.53 million and no purchases. The newest one on file is from May 15, 2026 (Coltharp Douglas Edward, Chief Financial Officer).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through May 15, 2026.

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| BlackRock Advisors LLC | 9.8 million | 9.96% | $1.2B |
| T. Rowe Price International Ltd. | 5.1 million | 5.13% | $608.0M |
| Vanguard Portfolio Management LLC | 4.9 million | 4.99% | $592.0M |
| Vanguard Capital Management LLC | 4.5 million | 4.54% | $538.0M |
| Wellington Trust Co., NA | 3.3 million | 3.32% | $394.0M |
| State Street Corporation | 3.2 million | 3.23% | $383.0M |
| Citadel Securities GP LLC | 2.6 million | 2.60% | $308.0M |
| AllianceBernstein LP | 2.5 million | 2.50% | $297.0M |
| Fuller & Thaler Asset Management, Inc. | 2.5 million | 2.49% | $296.0M |
| Two Sigma Investments LP | 2.3 million | 2.30% | $273.0M |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 619 | – | $9.7B |
| Q1 2026 | 599 | 96.4 million | $9.3B |
| Q4 2025 | 613 | 102.0 million | $10.8B |
| Q3 2025 | 628 | 95.5 million | $12.1B |
| Q2 2025 | 626 | 95.2 million | $11.7B |
| Q1 2025 | 561 | 96.7 million | $9.8B |
| Q4 2024 | 568 | 95.8 million | $8.8B |
| Q3 2024 | 506 | 98.2 million | $9.5B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Coltharp Douglas Edward | May 15, 2026 | Chief Financial Officer | Sale at price 106.83 - 107.28 per share. | $3.0M |
| Coltharp Douglas Edward | May 15, 2026 | Chief Financial Officer | Conversion of Exercise of derivative security at price 32.94 per share. | $912,240 |
| Tuer Patrick William | May 11, 2026 | Chief Operating Officer | Sale at price 104.56 per share. | $71,310 |
| Herman Joan E | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Katz Leslye G | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Williams Terrance | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| O'Connor Kevin J | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Hayes Cain A. | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Reidy Christopher R | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Carmichael Gregory D | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Christie Edward M Iii | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Schlichting Nancy M | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
Newest 12 of 91 insider transactions in the last two years.
BlackRock Advisors LLC, with 9.96% of the company (as of September 25, 2026). Next: T. Rowe Price International Ltd. (5.13%) and Vanguard Portfolio Management LLC (4.99%).
619 institutional holdings reports listed Encompass Health shares in Q2 2026 worth $9.74 billion.
In the last two years insiders reported 10 sales and no purchases (91 transactions in all); the newest on file is from May 15, 2026.